glp-1 surgery guidance news GLP-1 Drugs vs. Bariatric Surgery -mvanhaasteren.nl Study: Most Patients Can Safely
Description
Why this matters (and dont underestimate it): ~20% weight loss in non-diabetic obesity (REDEFINE-1) 1416% weight loss in T2D (REDEFINE-2) Dual mechanism = appetite suppression + satiety reinforcement Designed for long-term maintenance, not just short-term loss Potentially better GI tolerability with flexible titration This isnt another GLP-1. Its a clear signal that amylin is emerging as a serious second pillar in next-gen obesity care

Employers have much to consider in terms of cost coverage and affiliated support programs.

There is a high correlation of PAD and coronary events including heart attacks. This study aimed to explore the impact of GLP-1 RAs on cardiovascular outcomes in patients with moderate PAD

Stir thoroughly and enjoy any time of day

GLP-1, semaglutide & tirzepatide programs tailored to your biology

Cooling: Temperature controlled with overheating protection
